Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34
+
hematopoietic progenitor cells in patients with sickle cell disease: interim results
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now